Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
Behzad Hajarizadeh(UNSW Sydney), Homie Razavi(Center for Disease Analysis), Reza Malekzadeh(Tehran University of Medical Sciences), Seyed Moayed Alavian(Middle East Liver Disease Center), Devin Razavi‐Shearer(University of Health Sciences Antigua), Shahin Merat(Non-Communicable Diseases Research Center)
Cited by 52
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
|JAMA Oncology|2017|2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484